These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70. Bergmark BA; Marston NA; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Park JG; Murphy SA; Verma S; Wojakowski W; Terra SG; Sabatine MS; Wiviott SD; Circulation; 2022 May; 145(18):1377-1386. PubMed ID: 35369705 [TBL] [Abstract][Full Text] [Related]
8. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis. Mohamed F; Mansfield BS; Raal FJ Curr Atheroscler Rep; 2022 Dec; 24(12):959-967. PubMed ID: 36367663 [TBL] [Abstract][Full Text] [Related]
9. Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. Zimerman A; Wiviott SD; Park JG; Murphy SA; Ran X; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Verma S; Wojakowski W; Terra SG; Sabatine MS; Bergmark BA; Marston NA Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38484368 [TBL] [Abstract][Full Text] [Related]
10. ANGPTL3 Deficiency and Risk of Hepatic Steatosis. D'Erasmo L; Di Martino M; Neufeld T; Fraum TJ; Kang CJ; Burks KH; Di Costanzo A; Minicocci I; Bini S; Maranghi M; Pigna G; Labbadia G; Zheng J; Fierro D; Montali A; Ceci F; Catalano C; Davidson NO; Lucisano G; Nicolucci A; Arca M; Stitziel NO Circulation; 2023 Nov; 148(19):1479-1489. PubMed ID: 37712257 [TBL] [Abstract][Full Text] [Related]
11. A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides. Wu X; Yu J; Ge B; Wang J; Han X; Zhang C; Mao X; Kalluru H; Bramson C; Terra SG; Liu J Drugs R D; 2024 Jul; ():. PubMed ID: 38949758 [TBL] [Abstract][Full Text] [Related]
13. ANGPTL3 as therapeutic target. Kersten S Curr Opin Lipidol; 2021 Dec; 32(6):335-341. PubMed ID: 34581310 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia. Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia. Mohamed F; Botha TC; Raal FJ Curr Opin Lipidol; 2021 Aug; 32(4):213-218. PubMed ID: 33883446 [TBL] [Abstract][Full Text] [Related]
16. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. Rosenson RS; Gaudet D; Hegele RA; Ballantyne CM; Nicholls SJ; Lucas KJ; San Martin J; Zhou R; Muhsin M; Chang T; Hellawell J; Watts GF; N Engl J Med; 2024 May; ():. PubMed ID: 38809174 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia. Ahmad Z; Banerjee P; Hamon S; Chan KC; Bouzelmat A; Sasiela WJ; Pordy R; Mellis S; Dansky H; Gipe DA; Dunbar RL Circulation; 2019 Aug; 140(6):470-486. PubMed ID: 31242752 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis. Mak LY; Gane E; Schwabe C; Yoon KT; Heo J; Scott R; Lee JH; Lee JI; Kweon YO; Weltman M; Harrison SA; Neuschwander-Tetri BA; Cusi K; Loomba R; Given BD; Christianson DR; Garcia-Medel E; Yi M; Hamilton J; Yuen MF J Hepatol; 2023 Apr; 78(4):684-692. PubMed ID: 36513186 [TBL] [Abstract][Full Text] [Related]
19. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623 [TBL] [Abstract][Full Text] [Related]
20. Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors. Tomlinson B; Wu QY; Zhong YM; Li YH J Lipid Atheroscler; 2024 Jan; 13(1):2-20. PubMed ID: 38299167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]